THE FOUR PILLAR-benefits of using IV3000 as an IV site dressing
Risk of infection:
Reduces risk of infection through;
- Reducing bacteria growth by preventing moisture accumulation thanks to IV3000 film that allows optimum moisture vapour transfer1-4;
- Acting as a bacterial barrier5,6;
- Acting as a viral barrier7;
- Lowering incidence of device related septicemia3
Patient comfort
Provides greater patient comfort8 by:
- Reducing pain on removal9;
- Acting as a waterproof film, patient can shower with the dressing on10-12.
Skin integrity
Maintains skin integrity through other product features:
- Low allergy adhesive3,4,9,13;
- Prevents skin maceration1-2,11;
- Non-irritating13;
- Non-sensitizing13.
Clinical practice
Supports good clinical practice through:
- Providing excellent catheter stability but easy to remove3,9,14-15;
- The ability to be applied easily aseptically and removed easily9;
- Minimizing unscheduled dressing changes16;
- Permits the dressing to stay in place for up to 7 days10,17-18;
- Permits continuous visualization of the catheter site
References
1 M. Richardson, An in vivo assessment of the microbial proliferation beneath transparent film dressing, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Symposium Series No.179. Royal Society of Medicine Services Limited, 1991, pp. 29-33.
2 B. Joyeux, OPSITE™ IV3000 versus Tegaderm™ on peripheral venous catheters, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Symposium Series No.179. Royal Society of Medicine Services Limited, 1991, pp. 53-55.
3 D. G. M. Maki, S. S. M. Stolz, S. B. Wheeler and L. A. D. S. Memel, "A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: Implications for catheter management," Critcial Care Medicine, vol. 22, no. 11, pp. 1729-1737, 1994.
4 D. G. Maki, "Preliminary Analysis of Data from the Triple-Lumen Central Venous Catheter Study," 1992.
5 Smith & Nephew, "Data On File Report 0505005. In-vitro," 2005.
6 Smith & Nephew, "Bacteria barrier testing of IV3000 Report WRP-TW042-281," 2003.
7 Smith & Nephew, Bacterial Viral Barrier Claim For IV3000 Transparent Dressing Family. Statement Reference 200409902-01, 2004.
8 S. Wheeler, S. Stolz and D. Maki, "A prospective, randomized, three-way clinical comparison of a novel, highly permeable, polyurethane dressing with 206 Swan-Ganz pulmonary artery catheters: OPSITE IV3000 vs Tegaderm vs gauze and tape," pp. 67-72, 1991.
9 J. Willie, B. Van Oud Alblas and E. Thewessen, "A comparison of two transparent film-type dressing in central vanous therapy," Journal of Hospital Infection, vol. 23, pp. 113-121, 1993.
10 M. Besley, OPSITE IV3000: potential for improved quality of life for haemodialysis patients with permanent central venous catheters, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Synposium Series No. 179. Royal Society of Medicine Services Limited, 1991, pp. 57-59.
11 L. Tompkins, "Data on File Report DS/07/224/R1a. IV3000 I-Hand Physical Properties.," 2008.
12 "Preventing Hospital- Acquired Infection- Clinical Guidelines Public Health Laboratory Service," 1997.
13 G. Walton, "Safety Statement," 2011.
14 A. Wallace and B. Davy, "Report Ref. L/75A/23. To evaluate the skin response to, and tape performance of, single and repeat applications of high MVP dressings in human volunteers.," 1985.
15 D. Maki and M. Ringer, "Evalutation of Dressing Regimens for Prevention of Infection With Peripheral Intravenous Catheters," JAMA, vol. 258, no. 17, pp. 2395-2403, 6 Nov 1987.
16 M. Neufeld, A Randomized Control Trial of the effectiveness of Opsite Wound versus IV3000 in maintaining and Occlusive Central Line Dressing, McMaster University Canada, 1991.
17 D. R. R. Keenlyside, "Avoiding an unnecessary outcome. A comparative trial between IV3000 and a conventional film dressing to assess rates of catheter-related sepsis," Professional Nurse, pp. 288-291, February 1993.
18 C. Latta and C. Grant, "IV3000 dressing on Permcath exit sites," 1996.
All Trademarks acknowledged
The information on the date label in the banner image is for promotional purposes only.